Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12672-023-00652-z.

Title:
RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis | Discover Oncology
Description:
Breast cancer is the most common malignancy among women and the leading cause of cancer deaths, with complicated pathogenesis that is largely unknown. In this study, we identified a novel long non-coding RNA (lncRNA) as a critical driver of breast cancer tumorigenesis. RUNX1 intronic transcript 1 (RUNX1-IT1) was notably overexpressed in human breast cancer tissues, and knockdown of RUNX1-IT1 inhibited breast cancer cell viability and invasion, as well as tumor growth in orthotopic transplantation model. Further, RUNX1-IT1 repressed ferroptosis, a novel iron-dependent form of regulated cell death, via increasing glutathione peroxidase 4 (GPX4) expression. Specifically, RUNX1-IT1 directly bound to N6-methyladenosine m6A reader IGF2BP1 and promoted the formation of (insulin like growth factor 2 mRNA binding protein 1) IGF2BP1 liquid-liquid phase separation (LLPS) biomolecular condensates, resulting in more IGF2BP1 occupation on GPX4 mRNA, increasing GPX4 mRNA stability. Moreover, high RUNX1-IT1 was linked to poor prognosis, and a strong positive correlation between RUNX1-IT1 and GPX4 was observed in clinical breast cancer tissues. Taken together, our data reveal that RUNX1-IT1 promotes breast cancer carcinogenesis through blocking ferroptosis via elevating GPX4, targeting of the previously unappreciated regulatory axis of RUNX1-IT1/IGF2BP1/GPX4 may be a promising treatment for patient with breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

runxit, cancer, breast, gpx, igfbp, fig, pubmed, article, cell, cells, google, scholar, expression, ferroptosis, cas, lncrna, mrna, protein, rna, study, assay, tissues, binding, llps, mdamb, central, analysis, function, wang, knockdown, tumor, data, death, lipid, human, levels, qrtpcr, runxitsilenced, testing, regulation, analyzed, liu, patients, mutant, results, showed, full, noncoding, model, separation,

Topics {✒️}

stat1-tincr-usp20-pd-l1 axis runx1-it1-silenced cells treated runx1-it1-silenced cells transfected liquid-liquid phase separation runx1-it1/igf2bp1 liquid droplets recent evidence shows runx1-it1-overexpressed cells transfected proto-oncogene protein eif4e runx1-it1-silenced cells article download pdf c18-reversedphase analytical column runx1-it1 affected ferroptosis downregulating mir-199a-5p runx1-it1-silenced group runx1-it1 repressed ferroptosis mda-mb-231 cell lysates gradient sds-polyacrylamide gel membrane-bound organelle dynamics maximal tumor size/burden runx1-it1-silenced t47d human pan-carcinoma tissues stable runx1-it1 knockdown runx1-it1 directly bound mda-mb-231 cell death breast cancer carcinogenesis q-exactive mass spectrometer runx1-it1 elevates gpx4 higher runx1-it1 levels emerging evidence suggests runx1-it1 induces ferroptosis shrnas targeting runx1-it1 full-length coding sequences qrt-pcr analysis testing runx1-it1-overexpressed cells study rna-protein interactions accumulated evidence shows emerging evidence shows cell-cell interaction mediated runx1-it1 expression levels regulating igf2bp1/gpx4 axis runx1-it1-mediated regulation avoid rna degradation anti-gfp magnetic beads purified gfp-igf2bp1 protein patient-derived tumor xenograft runx1-it1 promotes fatty acid oxidation runx1-it1/igf2bp1/gpx4 lung cancer cells kaplan-meier survival curve

Schema {🗺️}

WebPage:
      mainEntity:
         headline:RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis
         description:Breast cancer is the most common malignancy among women and the leading cause of cancer deaths, with complicated pathogenesis that is largely unknown. In this study, we identified a novel long non-coding RNA (lncRNA) as a critical driver of breast cancer tumorigenesis. RUNX1 intronic transcript 1 (RUNX1-IT1) was notably overexpressed in human breast cancer tissues, and knockdown of RUNX1-IT1 inhibited breast cancer cell viability and invasion, as well as tumor growth in orthotopic transplantation model. Further, RUNX1-IT1 repressed ferroptosis, a novel iron-dependent form of regulated cell death, via increasing glutathione peroxidase 4 (GPX4) expression. Specifically, RUNX1-IT1 directly bound to N6-methyladenosine m6A reader IGF2BP1 and promoted the formation of (insulin like growth factor 2 mRNA binding protein 1) IGF2BP1 liquid-liquid phase separation (LLPS) biomolecular condensates, resulting in more IGF2BP1 occupation on GPX4 mRNA, increasing GPX4 mRNA stability. Moreover, high RUNX1-IT1 was linked to poor prognosis, and a strong positive correlation between RUNX1-IT1 and GPX4 was observed in clinical breast cancer tissues. Taken together, our data reveal that RUNX1-IT1 promotes breast cancer carcinogenesis through blocking ferroptosis via elevating GPX4, targeting of the previously unappreciated regulatory axis of RUNX1-IT1/IGF2BP1/GPX4 may be a promising treatment for patient with breast cancer.
         datePublished:2023-04-10T00:00:00Z
         dateModified:2023-04-10T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s12672-023-00652-z
         keywords:
            Long non-coding RNA
            Breast cancer
            Ferroptosis
            m6A reader
            mRNA stability
            Oncology
            Cancer Research
            Surgical Oncology
            Molecular Medicine
            Radiotherapy
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig6_HTML.png
         isPartOf:
            name:Discover Oncology
            issn:
               2730-6011
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shengting Wang
               affiliation:
                     name:Xi’an Peihua University
                     address:
                        name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yufang Wang
               affiliation:
                     name:Xi’an Peihua University
                     address:
                        name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qian Li
               affiliation:
                     name:Xi’an Peihua University
                     address:
                        name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaixuan Zeng
               affiliation:
                     name:Xi’an Jiaotong University
                     address:
                        name:School of Medicine, Xi’an Jiaotong University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoming Li
               affiliation:
                     name:Xi’an Peihua University
                     address:
                        name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinghua Feng
               affiliation:
                     name:Xi’an Peihua University
                     address:
                        name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis
      description:Breast cancer is the most common malignancy among women and the leading cause of cancer deaths, with complicated pathogenesis that is largely unknown. In this study, we identified a novel long non-coding RNA (lncRNA) as a critical driver of breast cancer tumorigenesis. RUNX1 intronic transcript 1 (RUNX1-IT1) was notably overexpressed in human breast cancer tissues, and knockdown of RUNX1-IT1 inhibited breast cancer cell viability and invasion, as well as tumor growth in orthotopic transplantation model. Further, RUNX1-IT1 repressed ferroptosis, a novel iron-dependent form of regulated cell death, via increasing glutathione peroxidase 4 (GPX4) expression. Specifically, RUNX1-IT1 directly bound to N6-methyladenosine m6A reader IGF2BP1 and promoted the formation of (insulin like growth factor 2 mRNA binding protein 1) IGF2BP1 liquid-liquid phase separation (LLPS) biomolecular condensates, resulting in more IGF2BP1 occupation on GPX4 mRNA, increasing GPX4 mRNA stability. Moreover, high RUNX1-IT1 was linked to poor prognosis, and a strong positive correlation between RUNX1-IT1 and GPX4 was observed in clinical breast cancer tissues. Taken together, our data reveal that RUNX1-IT1 promotes breast cancer carcinogenesis through blocking ferroptosis via elevating GPX4, targeting of the previously unappreciated regulatory axis of RUNX1-IT1/IGF2BP1/GPX4 may be a promising treatment for patient with breast cancer.
      datePublished:2023-04-10T00:00:00Z
      dateModified:2023-04-10T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s12672-023-00652-z
      keywords:
         Long non-coding RNA
         Breast cancer
         Ferroptosis
         m6A reader
         mRNA stability
         Oncology
         Cancer Research
         Surgical Oncology
         Molecular Medicine
         Radiotherapy
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-023-00652-z/MediaObjects/12672_2023_652_Fig6_HTML.png
      isPartOf:
         name:Discover Oncology
         issn:
            2730-6011
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shengting Wang
            affiliation:
                  name:Xi’an Peihua University
                  address:
                     name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yufang Wang
            affiliation:
                  name:Xi’an Peihua University
                  address:
                     name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qian Li
            affiliation:
                  name:Xi’an Peihua University
                  address:
                     name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaixuan Zeng
            affiliation:
                  name:Xi’an Jiaotong University
                  address:
                     name:School of Medicine, Xi’an Jiaotong University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoming Li
            affiliation:
                  name:Xi’an Peihua University
                  address:
                     name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinghua Feng
            affiliation:
                  name:Xi’an Peihua University
                  address:
                     name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Discover Oncology
      issn:
         2730-6011
      volumeNumber:14
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Xi’an Peihua University
      address:
         name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
         type:PostalAddress
      name:Xi’an Peihua University
      address:
         name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
         type:PostalAddress
      name:Xi’an Peihua University
      address:
         name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
         type:PostalAddress
      name:Xi’an Jiaotong University
      address:
         name:School of Medicine, Xi’an Jiaotong University, Xi’an, China
         type:PostalAddress
      name:Xi’an Peihua University
      address:
         name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
         type:PostalAddress
      name:Xi’an Peihua University
      address:
         name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shengting Wang
      affiliation:
            name:Xi’an Peihua University
            address:
               name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yufang Wang
      affiliation:
            name:Xi’an Peihua University
            address:
               name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Qian Li
      affiliation:
            name:Xi’an Peihua University
            address:
               name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Kaixuan Zeng
      affiliation:
            name:Xi’an Jiaotong University
            address:
               name:School of Medicine, Xi’an Jiaotong University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Xiaoming Li
      affiliation:
            name:Xi’an Peihua University
            address:
               name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Xinghua Feng
      affiliation:
            name:Xi’an Peihua University
            address:
               name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
      name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
      name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
      name:School of Medicine, Xi’an Jiaotong University, Xi’an, China
      name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China
      name:Clinical Medical Center, Xi’an Peihua University, Xi’an, China

External Links {🔗}(158)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.7s.